Bioharmony, Boehringer to advance bacteriophage lysin therapeutics to treat MDR bacterial infections

Image: Bioharmony Therapeutics and Boehringer Ingelheim have collaborated to advance bacteriophage lysin therapeutics to treat f multi-drug resistant bacterial infection. Photo: courtesy of renjith Krishnan / FreeDigitalPhotos.net.